DISODIUM GUANOSINE 5-MONOPHOSPHATE,LACTOFERRIN

The U.S. FDA approved disodium guanosine 5-monophosphate + lactoferrin on 8 January 2010. This medicine belongs to a group of monoclonal antibodies (a protein made from specific immune cells).

Disodium guanosine 5-monophosphate + lactoferrin Injection treats iron deficiency and iron deficiency anemia in pregnant women.

Disodium guanosine 5-monophosphate + lactoferrin is available as a 100mg tablet which is administered orally. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition.

The common side effects that are experienced while you are on the treatment with disodium guanosine 5-monophosphate + lactoferrin are stomach upset and pain, constipation, vomiting.

The immune system may be modulated by lactoferrin. People who suffer from autoimmune diseases ought to use caution and should speak with a physician prior to taking lactoferrin supplements. Lactoferrin binds to iron and may affect iron absorption. Individuals with iron overload conditions, such as hemochromatosis, should use lactoferrin under the guidance of a healthcare provider. It is recommended to consult with your doctor and take a proper dose as per the doctor's advice. Don't overdose on it.

Consult your doctor if you have allergic symptoms immediately. If you feel any persisting discomfort after using the medicine, speak with the doctor. It is unknown whether Disodium guanosine 5-monophosphate + lactoferrin is excreted in breast milk. So, before starting the treatment, inform your doctor if you are breastfeeding. Consult your doctor for more information.

Adequate water intake and electrolyte supplementation are recommended to address fluid loss associated with disodium guanosine 5-monophosphate and lactoferrin use. Avoid high-fat and processed foods, as these may exacerbate gastrointestinal symptoms. Seek medical attention if allergic reactions develop. Report any persistent discomfort following use of this medicine to your doctor.

Frimline Pvt. Ltd., [Accessed on 8th July 2021], https://www.larenon.com/wp-content/uploads/2019/02/FERRONOMIC.pdf James L. Zehnder, Agents Used in Cytopenias; Hematopoietic Growth Factors, Lange's Basic & Clinical Pharmacology, 14th Edition, 2018, 591-607. H.G. Watson, J.I.O. Craig, L.M. Manson, Blood disease, Davidson's Principles and Practice of Medicine, 22nd Edition, 2014, 989-1056.